-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allantoin in Epidermolysis Bullosa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allantoin in Epidermolysis Bullosa report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allantoin in Epidermolysis Bullosa Drug Details: Allantoin (SD-101) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pentosan Polysulfate Sodium in Osteoarthritis Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan Polysulfate Sodium in Osteoarthritis Pain Drug Details: Pentosan...
-
Product Insights
NewOlive Healthcare Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Olive Healthcare Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Olive Healthcare Inc. is a firm that is providing wellness and medical device services for quantitative body composition monitoring, which is an important aspect of the new prevention-based healthcare paradigm. The company is headquartered in Republic of Korea (South Korea). GlobalData's Medical Devices company profile report, “Olive Healthcare Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pentosan Polysulfate Sodium in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan Polysulfate Sodium in...
-
Product Insights
NewHernia Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hernia Repair Devices Pipeline Market Report Overview Hernia Repair Device is a hernia mesh used to cure a hernia. Hernia is a condition where an organ or tissue bulges out through a weak spot in the surrounding muscle or connective tissue and can arise in a variety of locations throughout the body, including the pelvis, abdomen, and diaphragm. The hernia repair devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at...
-
Sector Analysis
NewBronchiectasis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033
Bronchiectasis Market Report Overview The Bronchiectasis market across the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China) was valued at $1.4 billion in 2023 and the market will grow at a CAGR of more than 3% from 2023 to 2033. The 7MM (China, Japan, the United Kingdom, Spain, Italy, Germany, France, and the US). The market growth is attributed to the launch of brensocatib and an increase in the number of diagnosed prevalent cases of bronchiectasis. Bronchiectasis Market...
-
Sector Analysis
NewAttention Deficit Hyperactivity Disorder (ADHD) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Attention Deficit Hyperactivity Disorder (ADHD) Market Report Overview The ADHD market across the 7MM was valued at $11.9 billion in 2022. The market will decline at a CAGR of less than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with specific criteria for children and adults. ADHD is characterized by age-inappropriate, extreme, and impairing levels of inattention and/or hyperactivity and impulsivity. It is...
-
Sector Analysis
NewAmyotrophic Lateral Sclerosis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2029
Amyotrophic Lateral Sclerosis Market Report Overview Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a severely debilitating, rare, and ultimately fatal neurodegenerative condition caused by a combination of genetic and environmental factors. However, the causative pathogenic mechanisms in ALS remain unclear. The condition is characterized by progressive degeneration of both upper (UMNs) and lower motor (LMNs) neurons that leads to death, frequently from respiratory failure, within a few years. The 8MM includes the US, France, Germany,...
-
Thematic Analysis
Ukraine Conflict Impact – Thematic Intelligence
Reasons to buy the ‘Ukraine Conflict Impact’ thematic intelligence report: Find out who are the leading players in the Ukraine war impact theme, and where they sit in the value chain. Gain in-depth insight into the main trends shaping the Ukraine War Impact theme over the next 12 to 24 months; classified into three categories: technology trends, macroeconomic trends, and regulatory trends. Identify the leading companies and the key disruptor companies making their mark within the Ukraine War Impact theme....